Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of sequestering of triglyceride (GO:0010889) | 4.75623791 |
2 | valine metabolic process (GO:0006573) | 4.55174598 |
3 | fatty acid beta-oxidation (GO:0006635) | 4.31941875 |
4 | keratan sulfate catabolic process (GO:0042340) | 4.30213891 |
5 | branched-chain amino acid catabolic process (GO:0009083) | 3.95107275 |
6 | collagen fibril organization (GO:0030199) | 3.93925760 |
7 | fatty acid oxidation (GO:0019395) | 3.90021053 |
8 | lipid oxidation (GO:0034440) | 3.86181646 |
9 | branched-chain amino acid metabolic process (GO:0009081) | 3.84764434 |
10 | protein heterotrimerization (GO:0070208) | 3.74730440 |
11 | cell adhesion mediated by integrin (GO:0033627) | 3.72576609 |
12 | fatty acid catabolic process (GO:0009062) | 3.71380099 |
13 | signal peptide processing (GO:0006465) | 3.67677054 |
14 | extracellular fibril organization (GO:0043206) | 3.66799964 |
15 | low-density lipoprotein particle clearance (GO:0034383) | 3.66145324 |
16 | kidney mesenchyme development (GO:0072074) | 3.55685875 |
17 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.54873904 |
18 | virion attachment to host cell (GO:0019062) | 3.54557855 |
19 | adhesion of symbiont to host cell (GO:0044650) | 3.54557855 |
20 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.49519936 |
21 | type B pancreatic cell proliferation (GO:0044342) | 3.43570148 |
22 | fatty acid transmembrane transport (GO:1902001) | 3.41496407 |
23 | protein retention in ER lumen (GO:0006621) | 3.40981313 |
24 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.39863960 |
25 | biotin metabolic process (GO:0006768) | 3.38652015 |
26 | metanephric mesenchyme development (GO:0072075) | 3.38300591 |
27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.35008335 |
28 | brown fat cell differentiation (GO:0050873) | 3.28259343 |
29 | tricarboxylic acid metabolic process (GO:0072350) | 3.28021712 |
30 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.25788174 |
31 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.20751950 |
32 | monocarboxylic acid catabolic process (GO:0072329) | 3.15359309 |
33 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.15276407 |
34 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.14878237 |
35 | skin morphogenesis (GO:0043589) | 3.14159670 |
36 | positive regulation of fatty acid oxidation (GO:0046321) | 3.13810124 |
37 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.13280854 |
38 | L-phenylalanine catabolic process (GO:0006559) | 3.13280854 |
39 | carnitine shuttle (GO:0006853) | 3.11786576 |
40 | uterus development (GO:0060065) | 3.10449620 |
41 | carnitine metabolic process (GO:0009437) | 3.09817372 |
42 | transcytosis (GO:0045056) | 3.09291717 |
43 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.06437698 |
44 | fibril organization (GO:0097435) | 3.04458576 |
45 | nucleotide transmembrane transport (GO:1901679) | 3.01515591 |
46 | sulfur amino acid catabolic process (GO:0000098) | 2.98030657 |
47 | L-phenylalanine metabolic process (GO:0006558) | 2.96853846 |
48 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.96853846 |
49 | xenobiotic catabolic process (GO:0042178) | 2.92921957 |
50 | alpha-linolenic acid metabolic process (GO:0036109) | 2.90835614 |
51 | endosome to pigment granule transport (GO:0043485) | 2.90490261 |
52 | endosome to melanosome transport (GO:0035646) | 2.90490261 |
53 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.89976380 |
54 | Golgi transport vesicle coating (GO:0048200) | 2.89837988 |
55 | COPI coating of Golgi vesicle (GO:0048205) | 2.89837988 |
56 | response to redox state (GO:0051775) | 2.88462468 |
57 | endodermal cell differentiation (GO:0035987) | 2.87901035 |
58 | triglyceride catabolic process (GO:0019433) | 2.86216982 |
59 | lipid storage (GO:0019915) | 2.85548612 |
60 | amino-acid betaine metabolic process (GO:0006577) | 2.83006415 |
61 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.82462821 |
62 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.82299331 |
63 | triglyceride homeostasis (GO:0070328) | 2.80653611 |
64 | acylglycerol homeostasis (GO:0055090) | 2.80653611 |
65 | cellular response to ATP (GO:0071318) | 2.79790856 |
66 | acetyl-CoA metabolic process (GO:0006084) | 2.77118519 |
67 | extracellular matrix assembly (GO:0085029) | 2.76844326 |
68 | positive regulation of glycolytic process (GO:0045821) | 2.74228962 |
69 | lysine catabolic process (GO:0006554) | 2.72998873 |
70 | lysine metabolic process (GO:0006553) | 2.72998873 |
71 | protein hydroxylation (GO:0018126) | 2.72192750 |
72 | glyoxylate metabolic process (GO:0046487) | 2.72017501 |
73 | smooth muscle tissue development (GO:0048745) | 2.71973870 |
74 | short-chain fatty acid metabolic process (GO:0046459) | 2.71146935 |
75 | COPII vesicle coating (GO:0048208) | 2.70761286 |
76 | regulation of triglyceride catabolic process (GO:0010896) | 2.69647236 |
77 | peptidyl-proline hydroxylation (GO:0019511) | 2.67145718 |
78 | lipid particle organization (GO:0034389) | 2.65461824 |
79 | tricarboxylic acid cycle (GO:0006099) | 2.65344229 |
80 | negative regulation of lipid storage (GO:0010888) | 2.65099249 |
81 | regulation of cholesterol storage (GO:0010885) | 2.62126067 |
82 | magnesium ion transport (GO:0015693) | 2.61421450 |
83 | extracellular negative regulation of signal transduction (GO:1900116) | 2.60769674 |
84 | extracellular regulation of signal transduction (GO:1900115) | 2.60769674 |
85 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.60574241 |
86 | protein carboxylation (GO:0018214) | 2.60574241 |
87 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.60274360 |
88 | acyl-CoA biosynthetic process (GO:0071616) | 2.59742611 |
89 | thioester biosynthetic process (GO:0035384) | 2.59742611 |
90 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.59641016 |
91 | regulation of fatty acid oxidation (GO:0046320) | 2.57991137 |
92 | middle ear morphogenesis (GO:0042474) | 2.57854995 |
93 | regulation of metalloenzyme activity (GO:0048552) | 2.57704308 |
94 | membrane budding (GO:0006900) | 2.57243305 |
95 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.56935300 |
96 | glomerular basement membrane development (GO:0032836) | 2.55761889 |
97 | carnitine transmembrane transport (GO:1902603) | 2.55124019 |
98 | response to phenylpropanoid (GO:0080184) | 2.54926587 |
99 | seminiferous tubule development (GO:0072520) | 2.53940341 |
100 | carnitine transport (GO:0015879) | 2.52810486 |
101 | amino-acid betaine transport (GO:0015838) | 2.52810486 |
102 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.50661381 |
103 | oligosaccharide catabolic process (GO:0009313) | 2.50527446 |
104 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.50102948 |
105 | cysteine metabolic process (GO:0006534) | 2.50099457 |
106 | plasma lipoprotein particle clearance (GO:0034381) | 2.49811588 |
107 | intracellular lipid transport (GO:0032365) | 2.49262692 |
108 | complement activation, alternative pathway (GO:0006957) | 2.47879218 |
109 | collagen metabolic process (GO:0032963) | 2.47641452 |
110 | acylglycerol catabolic process (GO:0046464) | 2.47005773 |
111 | neutral lipid catabolic process (GO:0046461) | 2.47005773 |
112 | hindbrain development (GO:0030902) | 2.46655432 |
113 | exocrine pancreas development (GO:0031017) | 2.45710560 |
114 | cellular response to vitamin D (GO:0071305) | 2.45347351 |
115 | aromatic amino acid family catabolic process (GO:0009074) | 2.45124859 |
116 | collagen catabolic process (GO:0030574) | 2.43448744 |
117 | white fat cell differentiation (GO:0050872) | 2.43206911 |
118 | polyketide metabolic process (GO:0030638) | 2.42035942 |
119 | doxorubicin metabolic process (GO:0044598) | 2.42035942 |
120 | daunorubicin metabolic process (GO:0044597) | 2.42035942 |
121 | regulation of cholesterol metabolic process (GO:0090181) | 2.41820863 |
122 | 2-oxoglutarate metabolic process (GO:0006103) | 2.40987350 |
123 | heart contraction (GO:0060047) | 2.40318499 |
124 | heart process (GO:0003015) | 2.40318499 |
125 | negative regulation of protein autophosphorylation (GO:0031953) | 2.39794854 |
126 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.39096823 |
127 | organic acid catabolic process (GO:0016054) | 2.38111571 |
128 | carboxylic acid catabolic process (GO:0046395) | 2.38111571 |
129 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.37917986 |
130 | endocardial cushion development (GO:0003197) | 2.35562809 |
131 | peptide catabolic process (GO:0043171) | 2.34893514 |
132 | cellular response to vitamin (GO:0071295) | 2.34820794 |
133 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.34684961 |
134 | response to copper ion (GO:0046688) | 2.34190700 |
135 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.33478088 |
136 | tooth mineralization (GO:0034505) | 2.33223074 |
137 | cellular lipid catabolic process (GO:0044242) | 2.32729982 |
138 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.32586727 |
139 | thioester metabolic process (GO:0035383) | 2.32561670 |
140 | acyl-CoA metabolic process (GO:0006637) | 2.32561670 |
141 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.31906257 |
142 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.31895561 |
143 | metanephric tubule development (GO:0072170) | 2.31708697 |
144 | metanephric nephron tubule development (GO:0072234) | 2.31708697 |
145 | positive regulation of cartilage development (GO:0061036) | 2.31503528 |
146 | localization within membrane (GO:0051668) | 2.31418098 |
147 | positive regulation of lipid storage (GO:0010884) | 2.31067891 |
148 | adhesion of symbiont to host (GO:0044406) | 2.30959141 |
149 | bile acid biosynthetic process (GO:0006699) | 2.29168901 |
150 | purine ribonucleotide transport (GO:0015868) | 2.28762190 |
151 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.28599191 |
152 | lung vasculature development (GO:0060426) | 2.28466268 |
153 | regulation of plasminogen activation (GO:0010755) | 2.28334502 |
154 | metanephric nephron epithelium development (GO:0072243) | 2.28079116 |
155 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.27318002 |
156 | phagocytosis, recognition (GO:0006910) | 2.26948515 |
157 | homocysteine metabolic process (GO:0050667) | 2.26272749 |
158 | positive regulation of lipid catabolic process (GO:0050996) | 2.26044495 |
159 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.25511531 |
160 | multicellular organismal catabolic process (GO:0044243) | 2.25217939 |
161 | positive regulation of mitochondrial fission (GO:0090141) | 2.24890704 |
162 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.24818956 |
163 | muscle cell migration (GO:0014812) | 2.24369371 |
164 | regulation of triglyceride metabolic process (GO:0090207) | 2.23965682 |
165 | cell migration involved in heart development (GO:0060973) | 2.23745983 |
166 | polyol transport (GO:0015791) | 2.23054881 |
167 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.22115839 |
168 | acylglycerol biosynthetic process (GO:0046463) | 2.21606450 |
169 | neutral lipid biosynthetic process (GO:0046460) | 2.21606450 |
170 | tyrosine metabolic process (GO:0006570) | 2.21549994 |
171 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.21446631 |
172 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.21362613 |
173 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.20843574 |
174 | triglyceride biosynthetic process (GO:0019432) | 2.20757577 |
175 | multicellular organismal metabolic process (GO:0044236) | 2.20751738 |
176 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.20552512 |
177 | platelet dense granule organization (GO:0060155) | 2.17222337 |
178 | protein maturation by protein folding (GO:0022417) | 2.16816628 |
179 | wound healing, spreading of epidermal cells (GO:0035313) | 2.16365059 |
180 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.15925315 |
181 | pattern specification involved in kidney development (GO:0061004) | 2.15321110 |
182 | regulation of phospholipase A2 activity (GO:0032429) | 2.14087007 |
183 | lymphangiogenesis (GO:0001946) | 2.12901987 |
184 | tonic smooth muscle contraction (GO:0014820) | 2.12768338 |
185 | 4-hydroxyproline metabolic process (GO:0019471) | 2.12356828 |
186 | metanephric epithelium development (GO:0072207) | 2.10876093 |
187 | extracellular matrix disassembly (GO:0022617) | 2.09950176 |
188 | response to hyperoxia (GO:0055093) | 2.09625372 |
189 | response to increased oxygen levels (GO:0036296) | 2.09625372 |
190 | L-methionine biosynthetic process (GO:0071265) | 2.09360913 |
191 | amino acid salvage (GO:0043102) | 2.09360913 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.11324003 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.40927883 |
3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.04252597 |
4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.01329716 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.49049617 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.46486658 |
7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.42331589 |
8 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.11978412 |
9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.95619317 |
10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.87492515 |
11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.87309016 |
12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.87252186 |
13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.71702034 |
14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.59817676 |
15 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.53093306 |
16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.20631606 |
17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.15504057 |
18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.09789332 |
19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.09457008 |
20 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.06187318 |
21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.02818862 |
22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.98100547 |
23 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.90325387 |
24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.83582655 |
25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.79411480 |
26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.78806034 |
27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.78777475 |
28 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.76935295 |
29 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.76935295 |
30 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.71254988 |
31 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.64313374 |
32 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.62638630 |
33 | CJUN_26792858_Chip-Seq_BT549_Human | 1.61545020 |
34 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.60890922 |
35 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.57636572 |
36 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.54786454 |
37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50541194 |
38 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.50094930 |
39 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.48041787 |
40 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47472998 |
41 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.45979925 |
42 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.45949930 |
43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44918063 |
44 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.42260754 |
45 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.41814987 |
46 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40896809 |
47 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.39722690 |
48 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.36499026 |
49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.36025261 |
50 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.33947817 |
51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32902476 |
52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32089142 |
53 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.31620816 |
54 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.31557325 |
55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.28006498 |
56 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.26792606 |
57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.26367435 |
58 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.26212527 |
59 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.25298713 |
60 | TP53_16413492_ChIP-PET_HCT116_Human | 1.23802423 |
61 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.23677958 |
62 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.22303525 |
63 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.22303525 |
64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.21632637 |
65 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.21111270 |
66 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.20065659 |
67 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.19757740 |
68 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.18565427 |
69 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.15683355 |
70 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14696492 |
71 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14317617 |
72 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11616843 |
73 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.11275625 |
74 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10105889 |
75 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.09869230 |
76 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.08931250 |
77 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08556422 |
78 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.08354720 |
79 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.07719237 |
80 | VDR_22108803_ChIP-Seq_LS180_Human | 1.07559386 |
81 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.07037013 |
82 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06537226 |
83 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05117541 |
84 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.04831151 |
85 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.04341608 |
86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.03401273 |
87 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02959970 |
88 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.02730825 |
89 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02543386 |
90 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02446991 |
91 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00396443 |
92 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.99797574 |
93 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99658630 |
94 | AR_20517297_ChIP-Seq_VCAP_Human | 0.99546833 |
95 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.99213631 |
96 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99022923 |
97 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98020866 |
98 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.98020866 |
99 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.96994724 |
100 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96761067 |
101 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.95068429 |
102 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93910797 |
103 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92363288 |
104 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92034283 |
105 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.91971455 |
106 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91752072 |
107 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.91095819 |
108 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90873146 |
109 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.89818764 |
110 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89808251 |
111 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.88874957 |
112 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.88871798 |
113 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.88454674 |
114 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.88315088 |
115 | PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.88103513 |
116 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88023599 |
117 | CBP_21632823_ChIP-Seq_H3396_Human | 0.87231518 |
118 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.86171126 |
119 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85605207 |
120 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.85417404 |
121 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.84324648 |
122 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84249487 |
123 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.84006779 |
124 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.81840221 |
125 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.81667555 |
126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.81406973 |
127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81359449 |
128 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81263084 |
129 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80990958 |
130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80758461 |
131 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.80096361 |
132 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79394029 |
133 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.79182172 |
134 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.79182172 |
135 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.78165487 |
136 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.77713827 |
137 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.76439889 |
138 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.75950348 |
139 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.75278850 |
140 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.74735559 |
141 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73836215 |
142 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.72496584 |
143 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.72220405 |
144 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71773842 |
145 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.70686730 |
146 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.70470131 |
147 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.68952282 |
148 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.68386695 |
149 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.68109334 |
150 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67990636 |
151 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.66697500 |
152 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.65570170 |
153 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.64823144 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005670_abnormal_white_adipose | 4.10685438 |
2 | MP0008438_abnormal_cutaneous_collagen | 3.10562593 |
3 | MP0002139_abnormal_hepatobiliary_system | 3.01670634 |
4 | MP0005360_urolithiasis | 3.00235461 |
5 | MP0003195_calcinosis | 2.80492795 |
6 | MP0000013_abnormal_adipose_tissue | 2.52532049 |
7 | MP0003724_increased_susceptibility_to | 2.51468277 |
8 | MP0002837_dystrophic_cardiac_calcinosis | 2.42632127 |
9 | MP0005365_abnormal_bile_salt | 2.42316462 |
10 | MP0005666_abnormal_adipose_tissue | 2.23891168 |
11 | MP0004130_abnormal_muscle_cell | 2.23797493 |
12 | MP0005257_abnormal_intraocular_pressure | 2.18253206 |
13 | MP0003191_abnormal_cellular_cholesterol | 2.05913686 |
14 | MP0005623_abnormal_meninges_morphology | 2.03231886 |
15 | MP0005275_abnormal_skin_tensile | 2.02975674 |
16 | MP0003186_abnormal_redox_activity | 2.01927667 |
17 | MP0004272_abnormal_basement_membrane | 2.00864451 |
18 | MP0010329_abnormal_lipoprotein_level | 1.95348482 |
19 | MP0003011_delayed_dark_adaptation | 1.91155447 |
20 | MP0002971_abnormal_brown_adipose | 1.85753549 |
21 | MP0005085_abnormal_gallbladder_physiolo | 1.80624891 |
22 | MP0009780_abnormal_chondrocyte_physiolo | 1.76891461 |
23 | MP0005375_adipose_tissue_phenotype | 1.75674612 |
24 | MP0005332_abnormal_amino_acid | 1.73358155 |
25 | MP0001661_extended_life_span | 1.66739479 |
26 | MP0002138_abnormal_hepatobiliary_system | 1.66691015 |
27 | MP0009643_abnormal_urine_homeostasis | 1.66530803 |
28 | MP0001879_abnormal_lymphatic_vessel | 1.66093528 |
29 | MP0003252_abnormal_bile_duct | 1.60064068 |
30 | MP0002876_abnormal_thyroid_physiology | 1.59587012 |
31 | MP0008875_abnormal_xenobiotic_pharmacok | 1.52304382 |
32 | MP0003279_aneurysm | 1.50010725 |
33 | MP0002118_abnormal_lipid_homeostasis | 1.49878159 |
34 | MP0000003_abnormal_adipose_tissue | 1.49865675 |
35 | MP0004185_abnormal_adipocyte_glucose | 1.49698388 |
36 | MP0005503_abnormal_tendon_morphology | 1.49006907 |
37 | MP0003283_abnormal_digestive_organ | 1.45896879 |
38 | MP0001299_abnormal_eye_distance/ | 1.45097244 |
39 | MP0004043_abnormal_pH_regulation | 1.41492202 |
40 | MP0003806_abnormal_nucleotide_metabolis | 1.40881481 |
41 | MP0005084_abnormal_gallbladder_morpholo | 1.40853012 |
42 | MP0003868_abnormal_feces_composition | 1.37280411 |
43 | MP0004145_abnormal_muscle_electrophysio | 1.36184113 |
44 | MP0003941_abnormal_skin_development | 1.35609010 |
45 | MP0010386_abnormal_urinary_bladder | 1.34972101 |
46 | MP0010368_abnormal_lymphatic_system | 1.34567296 |
47 | MP0000751_myopathy | 1.30791614 |
48 | MP0005334_abnormal_fat_pad | 1.30749441 |
49 | MP0008775_abnormal_heart_ventricle | 1.30670808 |
50 | MP0004019_abnormal_vitamin_homeostasis | 1.30390425 |
51 | MP0005187_abnormal_penis_morphology | 1.26755119 |
52 | MP0003705_abnormal_hypodermis_morpholog | 1.26672251 |
53 | MP0001666_abnormal_nutrient_absorption | 1.24946589 |
54 | MP0006036_abnormal_mitochondrial_physio | 1.23800709 |
55 | MP0009384_cardiac_valve_regurgitation | 1.23097077 |
56 | MP0001764_abnormal_homeostasis | 1.23058925 |
57 | MP0001853_heart_inflammation | 1.22227052 |
58 | MP0001756_abnormal_urination | 1.22215257 |
59 | MP0005535_abnormal_body_temperature | 1.18384277 |
60 | MP0000767_abnormal_smooth_muscle | 1.18130090 |
61 | MP0002254_reproductive_system_inflammat | 1.17920279 |
62 | MP0002078_abnormal_glucose_homeostasis | 1.16751770 |
63 | MP0009115_abnormal_fat_cell | 1.16499270 |
64 | MP0005319_abnormal_enzyme/_coenzyme | 1.16206116 |
65 | MP0001958_emphysema | 1.14646538 |
66 | MP0009250_abnormal_appendicular_skeleto | 1.14545853 |
67 | MP0004510_myositis | 1.14342582 |
68 | MP0000609_abnormal_liver_physiology | 1.14195730 |
69 | MP0003950_abnormal_plasma_membrane | 1.12738291 |
70 | MP0002877_abnormal_melanocyte_morpholog | 1.11565820 |
71 | MP0003942_abnormal_urinary_system | 1.11248867 |
72 | MP0003828_pulmonary_edema | 1.11046603 |
73 | MP0000538_abnormal_urinary_bladder | 1.10411277 |
74 | MP0005379_endocrine/exocrine_gland_phen | 1.09456522 |
75 | MP0002295_abnormal_pulmonary_circulatio | 1.07656916 |
76 | MP0000343_altered_response_to | 1.06318284 |
77 | MP0000230_abnormal_systemic_arterial | 1.05422144 |
78 | MP0001243_abnormal_dermal_layer | 1.02588793 |
79 | MP0005595_abnormal_vascular_smooth | 1.02456065 |
80 | MP0002060_abnormal_skin_morphology | 1.02337695 |
81 | MP0005023_abnormal_wound_healing | 1.02080616 |
82 | MP0006054_spinal_hemorrhage | 1.00212168 |
83 | MP0005220_abnormal_exocrine_pancreas | 0.99580072 |
84 | MP0005636_abnormal_mineral_homeostasis | 0.98175851 |
85 | MP0001542_abnormal_bone_strength | 0.97516644 |
86 | MP0009764_decreased_sensitivity_to | 0.96548629 |
87 | MP0000163_abnormal_cartilage_morphology | 0.96004946 |
88 | MP0005164_abnormal_response_to | 0.94692639 |
89 | MP0000749_muscle_degeneration | 0.94197322 |
90 | MP0005058_abnormal_lysosome_morphology | 0.94059492 |
91 | MP0005330_cardiomyopathy | 0.93075404 |
92 | MP0003183_abnormal_peptide_metabolism | 0.91909431 |
93 | MP0002693_abnormal_pancreas_physiology | 0.90940264 |
94 | MP0000566_synostosis | 0.90515338 |
95 | MP0003122_maternal_imprinting | 0.90488911 |
96 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89937798 |
97 | MP0002896_abnormal_bone_mineralization | 0.89858602 |
98 | MP0002638_abnormal_pupillary_reflex | 0.89721983 |
99 | MP0001944_abnormal_pancreas_morphology | 0.89308998 |
100 | MP0003959_abnormal_lean_body | 0.89122298 |
101 | MP0001533_abnormal_skeleton_physiology | 0.88830367 |
102 | MP0006138_congestive_heart_failure | 0.88545178 |
103 | MP0002970_abnormal_white_adipose | 0.88178399 |
104 | MP0002168_other_aberrant_phenotype | 0.87585675 |
105 | MP0001881_abnormal_mammary_gland | 0.87320928 |
106 | MP0000750_abnormal_muscle_regeneration | 0.86778760 |
107 | MP0004782_abnormal_surfactant_physiolog | 0.84081775 |
108 | MP0002972_abnormal_cardiac_muscle | 0.83013126 |
109 | MP0003091_abnormal_cell_migration | 0.81772543 |
110 | MP0001544_abnormal_cardiovascular_syste | 0.81596745 |
111 | MP0005385_cardiovascular_system_phenoty | 0.81596745 |
112 | MP0005508_abnormal_skeleton_morphology | 0.81117934 |
113 | MP0005165_increased_susceptibility_to | 0.80248146 |
114 | MP0005620_abnormal_muscle_contractility | 0.79725181 |
115 | MP0003566_abnormal_cell_adhesion | 0.79046223 |
116 | MP0002136_abnormal_kidney_physiology | 0.77612745 |
117 | MP0005369_muscle_phenotype | 0.76795804 |
118 | MP0004084_abnormal_cardiac_muscle | 0.76341171 |
119 | MP0000534_abnormal_ureter_morphology | 0.75834385 |
120 | MP0003646_muscle_fatigue | 0.75611769 |
121 | MP0005390_skeleton_phenotype | 0.75521300 |
122 | MP0002108_abnormal_muscle_morphology | 0.75481926 |
123 | MP0004215_abnormal_myocardial_fiber | 0.75271050 |
124 | MP0003690_abnormal_glial_cell | 0.74704238 |
125 | MP0004036_abnormal_muscle_relaxation | 0.74101185 |
126 | MP0001986_abnormal_taste_sensitivity | 0.74022590 |
127 | MP0002115_abnormal_skeleton_extremities | 0.71970258 |
128 | MP0000747_muscle_weakness | 0.70248094 |
129 | MP0003172_abnormal_lysosome_physiology | 0.69615649 |
130 | MP0002234_abnormal_pharynx_morphology | 0.69574793 |
131 | MP0002135_abnormal_kidney_morphology | 0.69329063 |
132 | MP0002090_abnormal_vision | 0.69110740 |
133 | MP0003300_gastrointestinal_ulcer | 0.68573814 |
134 | MP0000049_abnormal_middle_ear | 0.68116706 |
135 | MP0000762_abnormal_tongue_morphology | 0.67546206 |
136 | MP0002106_abnormal_muscle_physiology | 0.66815448 |
137 | MP0002163_abnormal_gland_morphology | 0.65334674 |
138 | MP0004484_altered_response_of | 0.65042550 |
139 | MP0002128_abnormal_blood_circulation | 0.64488699 |
140 | MP0010030_abnormal_orbit_morphology | 0.60885043 |
141 | MP0002160_abnormal_reproductive_system | 0.59566017 |
142 | MP0009840_abnormal_foam_cell | 0.59130349 |
143 | MP0004087_abnormal_muscle_fiber | 0.58142231 |
144 | MP0000428_abnormal_craniofacial_morphol | 0.57986897 |
145 | MP0006072_abnormal_retinal_apoptosis | 0.57979392 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Premature rupture of membranes (HP:0001788) | 5.89748873 |
2 | Hypoglycemic coma (HP:0001325) | 5.55888717 |
3 | Protrusio acetabuli (HP:0003179) | 5.32596013 |
4 | Generalized aminoaciduria (HP:0002909) | 4.15620554 |
5 | Soft skin (HP:0000977) | 4.07574758 |
6 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.92112259 |
7 | Vascular tortuosity (HP:0004948) | 3.85549681 |
8 | Hyperglycinuria (HP:0003108) | 3.84642964 |
9 | Ketoacidosis (HP:0001993) | 3.80501267 |
10 | Aortic dissection (HP:0002647) | 3.74837860 |
11 | Hypoglycemic seizures (HP:0002173) | 3.61864462 |
12 | Proximal tubulopathy (HP:0000114) | 3.56616385 |
13 | Type 1 muscle fiber predominance (HP:0003803) | 3.53184217 |
14 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.51732298 |
15 | Follicular hyperkeratosis (HP:0007502) | 3.51552841 |
16 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.50414989 |
17 | Ankle contracture (HP:0006466) | 3.41888445 |
18 | Symptomatic seizures (HP:0011145) | 3.37990223 |
19 | Cardiovascular calcification (HP:0011915) | 3.23235832 |
20 | Ketosis (HP:0001946) | 3.20955637 |
21 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.19891915 |
22 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.16772017 |
23 | Dicarboxylic aciduria (HP:0003215) | 3.16772017 |
24 | Arterial tortuosity (HP:0005116) | 3.15054806 |
25 | Atrophic scars (HP:0001075) | 3.08175167 |
26 | Aortic aneurysm (HP:0004942) | 3.07871609 |
27 | Hyperglycemia (HP:0003074) | 3.02818963 |
28 | Myoglobinuria (HP:0002913) | 3.01120299 |
29 | Hepatic necrosis (HP:0002605) | 2.99877880 |
30 | Abnormality of glycine metabolism (HP:0010895) | 2.98882589 |
31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.98882589 |
32 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.97299147 |
33 | Abnormality of dentin (HP:0010299) | 2.95585734 |
34 | Bladder diverticulum (HP:0000015) | 2.90595803 |
35 | Vertebral compression fractures (HP:0002953) | 2.86599220 |
36 | Cervical subluxation (HP:0003308) | 2.85739569 |
37 | Facial diplegia (HP:0001349) | 2.82195677 |
38 | Wormian bones (HP:0002645) | 2.80944260 |
39 | Metaphyseal dysplasia (HP:0100255) | 2.80539944 |
40 | Infantile muscular hypotonia (HP:0008947) | 2.79353326 |
41 | Oligomenorrhea (HP:0000876) | 2.78011709 |
42 | Abnormality of the intrinsic pathway (HP:0010989) | 2.77811958 |
43 | Neonatal short-limb short stature (HP:0008921) | 2.76639890 |
44 | Vascular calcification (HP:0004934) | 2.76431394 |
45 | Hypoalphalipoproteinemia (HP:0003233) | 2.75659360 |
46 | Xanthomatosis (HP:0000991) | 2.74145767 |
47 | Nausea (HP:0002018) | 2.73481596 |
48 | Renal cortical cysts (HP:0000803) | 2.72657568 |
49 | Hydroxyprolinuria (HP:0003080) | 2.70173123 |
50 | Abnormality of proline metabolism (HP:0010907) | 2.70173123 |
51 | Increased serum pyruvate (HP:0003542) | 2.59571635 |
52 | Adrenal hypoplasia (HP:0000835) | 2.58159310 |
53 | Hypertriglyceridemia (HP:0002155) | 2.56268999 |
54 | Asymmetric septal hypertrophy (HP:0001670) | 2.54763309 |
55 | Insulin resistance (HP:0000855) | 2.54684528 |
56 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.53337333 |
57 | Hyperlipoproteinemia (HP:0010980) | 2.51795393 |
58 | Prolonged partial thromboplastin time (HP:0003645) | 2.50478285 |
59 | Abnormality of glycolipid metabolism (HP:0010969) | 2.50134177 |
60 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.50134177 |
61 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.50134177 |
62 | Dysostosis multiplex (HP:0000943) | 2.46555090 |
63 | Abnormality of urine glucose concentration (HP:0011016) | 2.44842158 |
64 | Glycosuria (HP:0003076) | 2.44842158 |
65 | Rhabdomyolysis (HP:0003201) | 2.44124613 |
66 | Abnormality of purine metabolism (HP:0004352) | 2.43336534 |
67 | Peritonitis (HP:0002586) | 2.42565112 |
68 | Acanthosis nigricans (HP:0000956) | 2.41236865 |
69 | Hyperammonemia (HP:0001987) | 2.40569590 |
70 | Slender build (HP:0001533) | 2.40434256 |
71 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.39586028 |
72 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.39586028 |
73 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.39586028 |
74 | Spondylolisthesis (HP:0003302) | 2.38898105 |
75 | Ovoid vertebral bodies (HP:0003300) | 2.33965550 |
76 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.33687314 |
77 | Complement deficiency (HP:0004431) | 2.32122330 |
78 | Increased muscle lipid content (HP:0009058) | 2.28986080 |
79 | Ulnar deviation of the wrist (HP:0003049) | 2.28918941 |
80 | Mitral stenosis (HP:0001718) | 2.27982804 |
81 | Cerebral edema (HP:0002181) | 2.26089778 |
82 | Acute encephalopathy (HP:0006846) | 2.24828099 |
83 | Vacuolated lymphocytes (HP:0001922) | 2.23256133 |
84 | Intrahepatic cholestasis (HP:0001406) | 2.19768025 |
85 | Bone cyst (HP:0012062) | 2.19524355 |
86 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.18880150 |
87 | Lethargy (HP:0001254) | 2.15747290 |
88 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.13385490 |
89 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.13385490 |
90 | Abnormal hemoglobin (HP:0011902) | 2.13235732 |
91 | Abnormality of the common coagulation pathway (HP:0010990) | 2.13126925 |
92 | Pancreatitis (HP:0001733) | 2.10025398 |
93 | Increased corneal curvature (HP:0100692) | 2.09979019 |
94 | Keratoconus (HP:0000563) | 2.09979019 |
95 | Joint stiffness (HP:0001387) | 2.08312209 |
96 | Blue sclerae (HP:0000592) | 2.07795534 |
97 | Broad metatarsal (HP:0001783) | 2.06540602 |
98 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.05167399 |
99 | Pulmonary artery stenosis (HP:0004415) | 2.04625652 |
100 | Myotonia (HP:0002486) | 2.03726977 |
101 | Hyperglycinemia (HP:0002154) | 2.03257628 |
102 | Genu recurvatum (HP:0002816) | 2.02727717 |
103 | Gout (HP:0001997) | 2.02550199 |
104 | Hypolipoproteinemia (HP:0010981) | 2.01866938 |
105 | Acute necrotizing encephalopathy (HP:0006965) | 2.01601594 |
106 | Increased purine levels (HP:0004368) | 2.00615733 |
107 | Hyperuricemia (HP:0002149) | 2.00615733 |
108 | Metabolic acidosis (HP:0001942) | 2.00177826 |
109 | Tetraparesis (HP:0002273) | 1.99425153 |
110 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.99212443 |
111 | Abnormal cartilage morphology (HP:0002763) | 1.97039084 |
112 | Abnormality of glycolysis (HP:0004366) | 1.95342271 |
113 | Pigmentary retinal degeneration (HP:0001146) | 1.94948919 |
114 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.93974647 |
115 | Vomiting (HP:0002013) | 1.93480419 |
116 | Fragile skin (HP:0001030) | 1.92831145 |
117 | Dilatation of the ascending aorta (HP:0005111) | 1.92604850 |
118 | Absent frontal sinuses (HP:0002688) | 1.92324313 |
119 | Abnormal delivery (HP:0001787) | 1.91226292 |
120 | Large for gestational age (HP:0001520) | 1.90588584 |
121 | Overgrowth (HP:0001548) | 1.90179765 |
122 | Beaking of vertebral bodies (HP:0004568) | 1.89726722 |
123 | Redundant skin (HP:0001582) | 1.89078733 |
124 | Hyperextensible skin (HP:0000974) | 1.87766084 |
125 | Toxemia of pregnancy (HP:0100603) | 1.87341213 |
126 | Abnormality of the acetabulum (HP:0003170) | 1.84220871 |
127 | Hepatocellular necrosis (HP:0001404) | 1.84041383 |
128 | Epidermoid cyst (HP:0200040) | 1.84039881 |
129 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.83340224 |
130 | Skin nodule (HP:0200036) | 1.83191522 |
131 | Delayed gross motor development (HP:0002194) | 1.81505525 |
132 | Lipoatrophy (HP:0100578) | 1.81270060 |
133 | Lipid accumulation in hepatocytes (HP:0006561) | 1.81125749 |
134 | Joint hemorrhage (HP:0005261) | 1.80145749 |
135 | Entropion (HP:0000621) | 1.79995143 |
136 | Lactic acidosis (HP:0003128) | 1.79653872 |
137 | Aortic valve stenosis (HP:0001650) | 1.79631646 |
138 | Irregular vertebral endplates (HP:0003301) | 1.78500594 |
139 | Exertional dyspnea (HP:0002875) | 1.78345784 |
140 | Prenatal maternal abnormality (HP:0002686) | 1.78166297 |
141 | Myocardial infarction (HP:0001658) | 1.77764266 |
142 | Hypercholesterolemia (HP:0003124) | 1.77530988 |
143 | Respiratory distress (HP:0002098) | 1.77371445 |
144 | Patent foramen ovale (HP:0001655) | 1.76972690 |
145 | Breech presentation (HP:0001623) | 1.76895785 |
146 | Tibial bowing (HP:0002982) | 1.76255412 |
147 | Late onset (HP:0003584) | 1.76076950 |
148 | Fat malabsorption (HP:0002630) | 1.75693463 |
149 | Enlarged kidneys (HP:0000105) | 1.74475739 |
150 | Short nail (HP:0001799) | 1.74457431 |
151 | Mitochondrial inheritance (HP:0001427) | 1.73423501 |
152 | Conjugated hyperbilirubinemia (HP:0002908) | 1.73003805 |
153 | Abnormality of the ischium (HP:0003174) | 1.71642747 |
154 | Enlarged penis (HP:0000040) | 1.71523109 |
155 | Progressive neurologic deterioration (HP:0002344) | 1.70538354 |
156 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.70370677 |
157 | Systemic lupus erythematosus (HP:0002725) | 1.70079191 |
158 | Aortic regurgitation (HP:0001659) | 1.70068201 |
159 | Hematochezia (HP:0002573) | 1.69459943 |
160 | Osteopenia (HP:0000938) | 1.69356208 |
161 | Abnormality of the frontal sinuses (HP:0002687) | 1.69281435 |
162 | Protuberant abdomen (HP:0001538) | 1.69224252 |
163 | Hypokalemia (HP:0002900) | 1.69088078 |
164 | Medial flaring of the eyebrow (HP:0010747) | 1.67776697 |
165 | Glucose intolerance (HP:0000833) | 1.67684204 |
166 | Wide anterior fontanel (HP:0000260) | 1.66695776 |
167 | Increased variability in muscle fiber diameter (HP:0003557) | 1.66668510 |
168 | Methylmalonic aciduria (HP:0012120) | 1.66102005 |
169 | Hemorrhage of the eye (HP:0011885) | 1.65929981 |
170 | Spinal rigidity (HP:0003306) | 1.65617157 |
171 | Tongue fasciculations (HP:0001308) | 1.65523123 |
172 | Osteoarthritis (HP:0002758) | 1.65443098 |
173 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.65232209 |
174 | Abnormality of nucleobase metabolism (HP:0010932) | 1.65117239 |
175 | Palpitations (HP:0001962) | 1.64754202 |
176 | Deep venous thrombosis (HP:0002625) | 1.64488656 |
177 | Hypokalemic alkalosis (HP:0001949) | 1.64072157 |
178 | Renal Fanconi syndrome (HP:0001994) | 1.63753720 |
179 | Mitral regurgitation (HP:0001653) | 1.63604171 |
180 | Abnormality of complement system (HP:0005339) | 1.62977015 |
181 | Long toe (HP:0010511) | 1.62450145 |
182 | Mucopolysacchariduria (HP:0008155) | 1.61955759 |
183 | Bradycardia (HP:0001662) | 1.60544284 |
184 | Abnormality of alanine metabolism (HP:0010916) | 1.59050960 |
185 | Hyperalaninemia (HP:0003348) | 1.59050960 |
186 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.59050960 |
187 | Joint laxity (HP:0001388) | 1.59037531 |
188 | Biconcave vertebral bodies (HP:0004586) | 1.58905698 |
189 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.56559637 |
190 | Hypoplasia of the odontoid process (HP:0003311) | 1.55544160 |
191 | Femoral bowing (HP:0002980) | 1.55075562 |
192 | Abnormality of the calf musculature (HP:0001430) | 1.54190642 |
193 | Nemaline bodies (HP:0003798) | 1.53841925 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK16 | 4.17137657 |
2 | BCKDK | 3.82989233 |
3 | INSRR | 3.69455974 |
4 | IRAK3 | 3.24079593 |
5 | CASK | 2.94856541 |
6 | TIE1 | 2.89087838 |
7 | LIMK1 | 2.65782810 |
8 | TESK1 | 2.60458849 |
9 | ERN1 | 2.57063368 |
10 | IRAK1 | 2.23301923 |
11 | SIK1 | 2.09532044 |
12 | MAP3K12 | 2.08516949 |
13 | EPHA3 | 2.08254420 |
14 | MAPK15 | 1.98559777 |
15 | ZAK | 1.93240844 |
16 | FRK | 1.86746739 |
17 | MYLK | 1.82874399 |
18 | PIK3CG | 1.73087289 |
19 | MST4 | 1.71224263 |
20 | MOS | 1.68747128 |
21 | PDK2 | 1.67353947 |
22 | DMPK | 1.67285267 |
23 | MAP3K3 | 1.65021302 |
24 | FGFR4 | 1.58399776 |
25 | NEK9 | 1.52989240 |
26 | MAP3K14 | 1.51134401 |
27 | PDK3 | 1.50448000 |
28 | PDK4 | 1.50448000 |
29 | STK38L | 1.49658290 |
30 | OBSCN | 1.47784198 |
31 | IRAK4 | 1.46076089 |
32 | KDR | 1.44156550 |
33 | ILK | 1.42243822 |
34 | MST1R | 1.41391647 |
35 | FLT3 | 1.40199445 |
36 | TGFBR2 | 1.38735542 |
37 | ADRBK2 | 1.38459219 |
38 | PIK3CA | 1.37491403 |
39 | TAOK2 | 1.36792551 |
40 | ARAF | 1.33801276 |
41 | PLK2 | 1.30283620 |
42 | WNK4 | 1.28471801 |
43 | NUAK1 | 1.27696578 |
44 | FGFR3 | 1.27621006 |
45 | WNK3 | 1.24333508 |
46 | IRAK2 | 1.18589466 |
47 | EPHB2 | 1.18013883 |
48 | MET | 1.16037477 |
49 | NLK | 1.15872230 |
50 | TBK1 | 1.15844409 |
51 | PTK2 | 1.15774089 |
52 | TEC | 1.10259290 |
53 | EPHB1 | 1.09097421 |
54 | IKBKE | 1.03758367 |
55 | BMPR2 | 1.02776117 |
56 | LATS1 | 1.00934186 |
57 | TAOK3 | 1.00875397 |
58 | TTN | 1.00781119 |
59 | CAMK2D | 1.00405859 |
60 | EPHA2 | 0.99115973 |
61 | JAK1 | 0.98637497 |
62 | NEK6 | 0.98595939 |
63 | FER | 0.97040848 |
64 | AKT3 | 0.96342421 |
65 | PRKAA2 | 0.95059886 |
66 | CAMK1D | 0.93833698 |
67 | PBK | 0.91641887 |
68 | BMPR1B | 0.87667318 |
69 | TRPM7 | 0.87503231 |
70 | PAK2 | 0.85403628 |
71 | TRIB3 | 0.84481717 |
72 | PNCK | 0.84106182 |
73 | NTRK1 | 0.83414215 |
74 | MAPKAPK3 | 0.82728384 |
75 | DAPK3 | 0.81048964 |
76 | TYK2 | 0.80984977 |
77 | TGFBR1 | 0.80732028 |
78 | STK38 | 0.80372318 |
79 | PDGFRA | 0.79532349 |
80 | PRKCE | 0.77028419 |
81 | MAP2K3 | 0.77008967 |
82 | GRK7 | 0.76174438 |
83 | ROCK2 | 0.76125498 |
84 | PLK4 | 0.75724656 |
85 | NME2 | 0.75198208 |
86 | ROCK1 | 0.74885472 |
87 | IKBKB | 0.74535996 |
88 | CAMK2G | 0.74039467 |
89 | PINK1 | 0.73038817 |
90 | TLK1 | 0.72523709 |
91 | JAK3 | 0.72290820 |
92 | EIF2AK3 | 0.72114805 |
93 | MAPK7 | 0.69105391 |
94 | ERBB3 | 0.66963794 |
95 | MARK1 | 0.66556855 |
96 | ABL2 | 0.66205064 |
97 | MAP4K2 | 0.65515880 |
98 | CHUK | 0.65318672 |
99 | IGF1R | 0.64507211 |
100 | ADRBK1 | 0.63998839 |
101 | BCR | 0.62816906 |
102 | EIF2AK2 | 0.61281785 |
103 | STK24 | 0.60481589 |
104 | RPS6KA4 | 0.57634791 |
105 | GRK1 | 0.56719641 |
106 | GSK3A | 0.55122979 |
107 | PAK3 | 0.54875809 |
108 | TRIM28 | 0.53446028 |
109 | ERBB4 | 0.52005973 |
110 | PRKD2 | 0.51192393 |
111 | TXK | 0.49364164 |
112 | PHKG1 | 0.49247372 |
113 | PHKG2 | 0.49247372 |
114 | KIT | 0.48676304 |
115 | PRKG1 | 0.47756766 |
116 | HIPK2 | 0.46373592 |
117 | JAK2 | 0.44860712 |
118 | ABL1 | 0.43667886 |
119 | RPS6KA2 | 0.42855875 |
120 | PRKD1 | 0.42470343 |
121 | PTK6 | 0.41891886 |
122 | MAP3K13 | 0.41141091 |
123 | MAPK12 | 0.39987734 |
124 | RPS6KA5 | 0.39710375 |
125 | MAP2K1 | 0.39658548 |
126 | PTK2B | 0.38763986 |
127 | ZAP70 | 0.38675866 |
128 | CAMK2A | 0.36898464 |
129 | LMTK2 | 0.36226498 |
130 | PRKAA1 | 0.35141688 |
131 | PRKG2 | 0.34304358 |
132 | DYRK1B | 0.34186919 |
133 | PIM2 | 0.33834358 |
134 | MUSK | 0.33556721 |
135 | DDR2 | 0.33514274 |
136 | PKN1 | 0.33469285 |
137 | PDGFRB | 0.33276460 |
138 | STK3 | 0.33079038 |
139 | PRKACG | 0.32471201 |
140 | PRKD3 | 0.31919664 |
141 | CSNK1G2 | 0.30917170 |
142 | MAP3K5 | 0.30911699 |
143 | INSR | 0.30498468 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.30456757 |
2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.24229667 |
3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.21383638 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.05447023 |
5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.80762344 |
6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.71412400 |
7 | Protein export_Homo sapiens_hsa03060 | 2.65505625 |
8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.58119389 |
9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.50728454 |
10 | Peroxisome_Homo sapiens_hsa04146 | 2.23540981 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.02845496 |
12 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.02814907 |
13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.96448544 |
14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.89072388 |
15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.72091611 |
16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.69546017 |
17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.68916282 |
18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.67373907 |
19 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64605853 |
20 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.64109568 |
21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62517905 |
22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.58767173 |
23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.58723882 |
24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.48044920 |
25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42768255 |
26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.41480328 |
27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.40174070 |
28 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39569645 |
29 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38206609 |
30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37572369 |
31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.37407730 |
32 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.33675179 |
33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.33541302 |
34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.31774951 |
35 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.31652623 |
36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.28481853 |
37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.27419879 |
38 | Focal adhesion_Homo sapiens_hsa04510 | 1.24408083 |
39 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.23324113 |
40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21768702 |
41 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19886934 |
42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.19771136 |
43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.16708090 |
44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.14618809 |
45 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.14378839 |
46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.13898275 |
47 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.11269047 |
48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.08183550 |
49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.08144614 |
50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06703195 |
51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.05815935 |
52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04414364 |
53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03220175 |
54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03099775 |
55 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.93807818 |
56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92885677 |
57 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.91236767 |
58 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90766921 |
59 | Parkinsons disease_Homo sapiens_hsa05012 | 0.90688871 |
60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.89021460 |
61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88313484 |
62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87854187 |
63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.86835591 |
64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86138147 |
65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.83497931 |
66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83179738 |
67 | Phagosome_Homo sapiens_hsa04145 | 0.81745382 |
68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81246042 |
69 | ABC transporters_Homo sapiens_hsa02010 | 0.80620493 |
70 | Lysosome_Homo sapiens_hsa04142 | 0.80591785 |
71 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78563307 |
72 | Amoebiasis_Homo sapiens_hsa05146 | 0.75122954 |
73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.73794251 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.70728312 |
75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70373541 |
76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.70362966 |
77 | Malaria_Homo sapiens_hsa05144 | 0.69630882 |
78 | Alzheimers disease_Homo sapiens_hsa05010 | 0.66842442 |
79 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66818143 |
80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66792918 |
81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65686580 |
82 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.63916652 |
83 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63728947 |
84 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61480642 |
85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61389860 |
86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61304593 |
87 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.60254060 |
88 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.59968006 |
89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59771646 |
90 | Pertussis_Homo sapiens_hsa05133 | 0.59651218 |
91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59579662 |
92 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.54811843 |
93 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54109574 |
94 | Proteasome_Homo sapiens_hsa03050 | 0.52870954 |
95 | Melanoma_Homo sapiens_hsa05218 | 0.50715442 |
96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50596875 |
97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47892992 |
98 | Huntingtons disease_Homo sapiens_hsa05016 | 0.47392235 |
99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45862473 |
100 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44317433 |
101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.43833349 |
102 | Legionellosis_Homo sapiens_hsa05134 | 0.43680922 |
103 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.41886113 |
104 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.40608722 |
105 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.39137512 |
106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38986820 |
107 | Bladder cancer_Homo sapiens_hsa05219 | 0.38539998 |
108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38359144 |
109 | Mineral absorption_Homo sapiens_hsa04978 | 0.37733303 |
110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35872902 |
111 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35680948 |
112 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34508587 |
113 | Asthma_Homo sapiens_hsa05310 | 0.32054990 |
114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31323308 |
115 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.30105564 |
116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29315156 |
117 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.29203990 |
118 | Bile secretion_Homo sapiens_hsa04976 | 0.28048126 |
119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28012520 |
120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27426691 |
121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.27021013 |
122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24735638 |
123 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.24120703 |
124 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.22713173 |
125 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.21965529 |